Physician profile
John J Hunter
NPI 1124062500
$4,396.82
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $697 · 2021: $1,213 · 2022: $867 · 2023: $633 · 2024: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $832.93 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $593.45 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $362.49 | 2021-2023 | Verquvo |
| Amarin Pharma, INC. | $331.65 | 2020-2021 | |
| Abbott Laboratories | $289.63 | 2019-2022 | |
| Bardy Diagnostics, INC. | $249.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $235.47 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $175.98 | 2019-2023 | Xarelto |
| Amgen INC. | $166.41 | 2021-2024 | Repatha |
| Medtronic, INC. | $149.82 | 2022-2023 | Micra |
| Edwards Lifesciences Corporation | $144.09 | 2019-2024 | Sapien 3 Ultra Resilia |
| Lundbeck LLC | $123.65 | 2019-2020 | |
| Pfizer INC. | $123.35 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $120.76 | 2021-2024 | Farxiga, Wainua |
| Boston Scientific Corporation | $101.45 | 2022-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $98.98 | 2019-2024 | Uptravi, Opsumit |
| Argon Medical Devices, INC. | $61.55 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $59.48 | 2019-2023 | Eliquis |
| Esperion Therapeutics, INC. | $22.60 | 2021 | |
| Jazz Pharmaceuticals INC. | $22.04 | 2020 | |
| Irhythm Technologies, INC. | $21.98 | 2022 | |
| Medtronic Vascular, INC. | $20.75 | 2020 | |
| Heartflow, INC. | $19.19 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.09 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.95 | 2022 | |
| Angiodynamics, INC. | $13.28 | 2020 | |
| Philips North America LLC | $12.57 | 2020 | |
| Aegerion Pharmaceuticals, INC. | $11.83 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.